¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"complement-fixing antibody"¿¡ ´ëÇÑ ´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
complement fixing antibody
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
complement-fixing antibody
º¸Ã¼°íÁ¤ Ç×ü(ÜÍô÷ͳïÒù÷ô÷)
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
acquired antibody
"ȹµæÇ×ü (üòÔðù÷ô÷), ÈÄõ¼ºÇ×ü (ýô¸àõù÷ô÷)"
agglutinating antibody
ÀÀÁýÇ×ü(ëêó¢ù÷ô÷)
anti-idiotype antibody
Ç×(ù÷)À̵ð¿ÀŸÀÌÇÁ Ç×ü(ù÷ô÷)
anti-immunoglobulin antibody
Ç׸鿪(ù÷Øóæ¹)±Û·ÎºÒ¸° Ç×ü(ù÷ô÷)
antibody
Ç×ü(ù÷ô÷)
antibody binding fraction
Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
antibody combining site
Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
antibody dependent cellular cytotoxicity
Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
antibody diversity
Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
antibody fixation
Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
antibody formation
Ç×ü Çü¼º(ù÷ô÷û¡à÷)
antibody heterogeneity
Ç×ü ºÒ±ÕÀϼº(ù÷ô÷ÝÕгìéàõ)
antibody mediated hypersensitivity
Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
antibody response
Ç×ü ´ëÀÀ(ù÷ô÷Óßëë)
antibody specificity
Ç×ü ƯÀ̼º(ù÷ô÷÷åì¶àõ)
´ÙÀ½
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½